NCT01265953View on ClinicalTrials.gov

Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Prostate Cancer Prevention
Interventions
DRUG

SFN-rich broccoli sprout extract capsules

Four weeks SFN-rich broccoli sprout extract (BSE) capsules: 200µmol of SFN, 2 capsules (1 capsule B.I.D.) daily

DIETARY_SUPPLEMENT

Gelatin capsule containing microcrystalline cellulose.

Four weeks placebo capsules: 2 capsules (1 capsule B.I.D.) daily

Trial Locations (2)

97239

OHSU Knight Cancer Institute, Portland

Portland VA Medical Center, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Oregon State University

OTHER

collaborator

OHSU Knight Cancer Institute

OTHER

lead

Portland VA Medical Center

FED

NCT01265953 - Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation | Biotech Hunter | Biotech Hunter